6533b7d5fe1ef96bd1264669

RESEARCH PRODUCT

New Trends in the Treatment of Osteoporosis

Mario PasseriGiuseppe Barbagallo-sangiorgiLigia J. DominguezMario Barbagallo

subject

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentOsteoporosismedicinemedicine.diseaseIntensive care medicineConsensus developmentbusinessSkeleton (computer programming)Reduction (orthopedic surgery)Bone massBone remodeling

description

Osteoporosis is “a systemic disease characterized by a reduction in bone mass and a microarchitectonic alteration of the skeleton, with a consequent increase in skeleton fragility and susceptibility to fractures”, as defined by the last Consensus Development Conference1. With this definition, the alteration in skeletal structure, which is not yet easy to evaluate, becomes an important factor determining the risk of fracture of the osteoporotic patient, in addition to the bone mass, which to certain limit can be easily evaluated. This is an aspect that may create some problems at the time of taking a decision on how to proceed with a subject with decreased bone mass. Currently, the measurement of the quantity of bone present constitutes the basis to support any therapeutical decision2. The quantification of bone mass may be performed with DEXA, TAC or ultrasound, although this last method has not been yet adequately standardized.

https://doi.org/10.1007/978-1-4899-1483-5_29